Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

Grp78 as a therapeutic target for refractory head-neck cancer with CD24(-)CD44(+) stemness phenotype.

Chiu CC, Lee LY, Li YC, Chen YJ, Lu YC, Li YL, Wang HM, Chang JT, Cheng AJ.

Cancer Gene Ther. 2013 Nov;20(11):606-15. doi: 10.1038/cgt.2013.64. Epub 2013 Nov 8.

PMID:
24201869
2.

Identification and characterization of cancer stem cells in human head and neck squamous cell carcinoma.

Han J, Fujisawa T, Husain SR, Puri RK.

BMC Cancer. 2014 Mar 11;14:173. doi: 10.1186/1471-2407-14-173.

3.

Glucose-regulated protein 78 regulates multiple malignant phenotypes in head and neck cancer and may serve as a molecular target of therapeutic intervention.

Chiu CC, Lin CY, Lee LY, Chen YJ, Kuo TF, Chang JT, Liao CT, Wang HM, Yen TC, Shen CR, Liao SK, Cheng AJ.

Mol Cancer Ther. 2008 Sep;7(9):2788-97. doi: 10.1158/1535-7163.MCT-08-0172.

4.

Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy.

Pham PV, Phan NL, Nguyen NT, Truong NH, Duong TT, Le DV, Truong KD, Phan NK.

J Transl Med. 2011 Dec 7;9:209. doi: 10.1186/1479-5876-9-209.

5.

Epithelial-mesenchymal transition transcription factor ZEB1/ZEB2 co-expression predicts poor prognosis and maintains tumor-initiating properties in head and neck cancer.

Chu PY, Hu FW, Yu CC, Tsai LL, Yu CH, Wu BC, Chen YW, Huang PI, Lo WL.

Oral Oncol. 2013 Jan;49(1):34-41. doi: 10.1016/j.oraloncology.2012.07.012. Epub 2012 Aug 11.

PMID:
22892238
6.

Elimination of head and neck cancer initiating cells through targeting glucose regulated protein78 signaling.

Wu MJ, Jan CI, Tsay YG, Yu YH, Huang CY, Lin SC, Liu CJ, Chen YS, Lo JF, Yu CC.

Mol Cancer. 2010 Oct 27;9:283. doi: 10.1186/1476-4598-9-283.

7.

Epithelial mesenchymal transition correlates with CD24+CD44+ and CD133+ cells in pancreatic cancer.

Zhang Y, Wei J, Wang H, Xue X, An Y, Tang D, Yuan Z, Wang F, Wu J, Zhang J, Miao Y.

Oncol Rep. 2012 May;27(5):1599-605. doi: 10.3892/or.2012.1681. Epub 2012 Feb 7.

PMID:
22322379
8.

Reduction of the putative CD44+CD24- breast cancer stem cell population by targeting the polyamine metabolic pathway with PG11047.

Cirenajwis H, Smiljanic S, Honeth G, Hegardt C, Marton LJ, Oredsson SM.

Anticancer Drugs. 2010 Nov;21(10):897-906. doi: 10.1097/CAD.0b013e32833f2f77.

PMID:
20838207
9.
10.

miR145 targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL-6-mediated paracrine effects in head and neck cancer.

Yu CC, Tsai LL, Wang ML, Yu CH, Lo WL, Chang YC, Chiou GY, Chou MY, Chiou SH.

Cancer Res. 2013 Jun 1;73(11):3425-40. doi: 10.1158/0008-5472.CAN-12-3840. Epub 2013 Apr 2. Erratum in: Cancer Res. 2015 Jul 1;75(13):2761.

11.

A CD44high/EGFRlow subpopulation within head and neck cancer cell lines shows an epithelial-mesenchymal transition phenotype and resistance to treatment.

La Fleur L, Johansson AC, Roberg K.

PLoS One. 2012;7(9):e44071. doi: 10.1371/journal.pone.0044071. Epub 2012 Sep 25.

12.

HER2-associated radioresistance of breast cancer stem cells isolated from HER2-negative breast cancer cells.

Duru N, Fan M, Candas D, Menaa C, Liu HC, Nantajit D, Wen Y, Xiao K, Eldridge A, Chromy BA, Li S, Spitz DR, Lam KS, Wicha MS, Li JJ.

Clin Cancer Res. 2012 Dec 15;18(24):6634-47. doi: 10.1158/1078-0432.CCR-12-1436. Epub 2012 Oct 22.

13.

Autophagy of cancer stem cells is involved with chemoresistance of colon cancer cells.

Wu S, Wang X, Chen J, Chen Y.

Biochem Biophys Res Commun. 2013 May 17;434(4):898-903. doi: 10.1016/j.bbrc.2013.04.053. Epub 2013 Apr 23.

PMID:
23624503
14.

Nuclear localization signal-enhanced RNA interference of EZH2 and Oct4 in the eradication of head and neck squamous cell carcinoma-derived cancer stem cells.

Lo WL, Chien Y, Chiou GY, Tseng LM, Hsu HS, Chang YL, Lu KH, Chien CS, Wang ML, Chen YW, Huang PI, Hu FW, Yu CC, Chu PY, Chiou SH.

Biomaterials. 2012 May;33(14):3693-709. doi: 10.1016/j.biomaterials.2012.01.016. Epub 2012 Feb 21.

PMID:
22361100
15.

A novel mouse model of human breast cancer stem-like cells with high CD44+CD24-/lower phenotype metastasis to human bone.

Ling LJ, Wang S, Liu XA, Shen EC, Ding Q, Lu C, Xu J, Cao QH, Zhu HQ, Wang F.

Chin Med J (Engl). 2008 Oct 20;121(20):1980-6.

PMID:
19080260
16.

Impairment of tumor-initiating stem-like property and reversal of epithelial-mesenchymal transdifferentiation in head and neck cancer by resveratrol treatment.

Hu FW, Tsai LL, Yu CH, Chen PN, Chou MY, Yu CC.

Mol Nutr Food Res. 2012 Aug;56(8):1247-58. doi: 10.1002/mnfr.201200150. Epub 2012 Jun 13.

PMID:
22692956
17.

CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.

Idowu MO, Kmieciak M, Dumur C, Burton RS, Grimes MM, Powers CN, Manjili MH.

Hum Pathol. 2012 Mar;43(3):364-73. doi: 10.1016/j.humpath.2011.05.005. Epub 2011 Aug 10.

PMID:
21835433
18.

Cucurbitacin I suppressed stem-like property and enhanced radiation-induced apoptosis in head and neck squamous carcinoma--derived CD44(+)ALDH1(+) cells.

Chen YW, Chen KH, Huang PI, Chen YC, Chiou GY, Lo WL, Tseng LM, Hsu HS, Chang KW, Chiou SH.

Mol Cancer Ther. 2010 Nov;9(11):2879-92. doi: 10.1158/1535-7163.MCT-10-0504. Epub 2010 Nov 9.

19.

Autophagy positively regulates the CD44(+) CD24(-/low) breast cancer stem-like phenotype.

Cufí S, Vazquez-Martin A, Oliveras-Ferraros C, Martin-Castillo B, Vellon L, Menendez JA.

Cell Cycle. 2011 Nov 15;10(22):3871-85. doi: 10.4161/cc.10.22.17976. Epub 2011 Nov 15.

PMID:
22127234
20.

Inhibition of Cdk2 kinase activity selectively targets the CD44⁺/CD24⁻/Low stem-like subpopulation and restores chemosensitivity of SUM149PT triple-negative breast cancer cells.

Opyrchal M, Salisbury JL, Iankov I, Goetz MP, McCubrey J, Gambino MW, Malatino L, Puccia G, Ingle JN, Galanis E, D'Assoro AB.

Int J Oncol. 2014 Sep;45(3):1193-9. doi: 10.3892/ijo.2014.2523. Epub 2014 Jun 25.

Items per page

Supplemental Content

Write to the Help Desk